PRP Consent Form Template for Med Spas (2026)

Not medical or legal advice. This page shows how a platelet-rich plasma consent form is commonly organized and what each section is there to prove. It sets no clinical standard, gives no processing settings or treatment schedules, and does not state the law of any state. Your practice's medical director must approve the final form and a healthcare attorney should review it before any patient signs.

Platelet-rich plasma has a reputation as the low-drama option on a regenerative menu. It is the patient's own blood, after all. That reputation is mostly deserved on the regulatory side, and it is why PRP consent forms drift: practices run a PRP add-on under two lines bolted onto the microneedling consent, or under a hair clinic's form describing a different kit and delivery route.

This guide covers one document: the patient consent for PRP and its close relative PRF, whether it is injected into the face or scalp or applied to microneedled skin. It walks through each section of the form, explains how to handle PRP that rides along with microneedling, and lists the weaknesses that surface in complaints. The wider compliance questions, including the regulatory status of PRP, blood handling and the scope stack behind the treatment, are covered in our PRP and PRF compliance guide. The general law of consent that applies to every service you offer is in our med spa consent forms guide.

Processing settings, volumes, session intervals and recovery timelines are deliberately absent. They belong in a clinical SOP signed by your medical director and checked against the kit's instructions for use, not on a patient-facing form.

What Must a PRP Consent Form Contain?

A PRP consent form must describe the blood draw, the processing and the delivery route, state that the product is the patient's own blood, name PRP or PRF, disclose that aesthetic use is off-label use of a cleared device, set realistic expectations, list risks in plain language, and record screening, alternatives, photo consent, aftercare, fees and signatures.

Audit your current form against each element below; every item is explained in the annotated template that follows.

1. Procedure description — the blood draw, the processing of the sample into a concentrate, and how the concentrate will be delivered (injection, application to microneedled skin, or both).
2. Product identity — whether the practice is preparing PRP or PRF, and the treatment areas.
3. Autologous nature — that the concentrate comes from the patient's own blood and is returned to the same patient at the same visit.
4. Regulatory status — that the processing device is FDA-cleared, that PRP itself is not an FDA-approved treatment, and that aesthetic use is off-label.
5. Expected results and variability — results differ between people, may be modest, may take more than one session, and are not guaranteed.
6. Common effects — the expected reactions at the draw site and the treatment site, separated from the risks.
7. Risks and side effects — named individually, in plain words, with space for initials.
8. Contraindication screening — questions the patient answers and the practitioner reviews before the draw.
9. Alternatives — other treatments and no treatment.
10. Photography consent — clinical photographs for the chart, with marketing use handled on a separate authorization.
11. Aftercare acknowledgment and warning signs — the handout was given and reviewed; the symptoms that mean the patient should call.
12. Financial terms — the fee, package and refund terms, and that payment does not buy a result.
13. Signatures, witness and date — patient attestation, practitioner identity and credential, the person who performed the draw if different, a witness where policy requires one, and the form version.

Why the signed form is not the whole of consent

Informed consent is the discussion. The form is the record of the discussion. A PRP form can be beautifully drafted and still prove very little if it was handed over by a receptionist and signed before the patient ever met the clinician who would draw their blood. When a complaint comes in, reviewers ask who explained the procedure, whether the off-label status was disclosed, and whether bleeding risk was asked about before the needle went in.

The strongest PRP records pair a specific form with a short chart note written at the visit: who held the conversation, that questions were answered, and any patient-specific concern, such as a history of fainting at blood draws.

Who Obtains PRP Consent, and Who May Draw and Inject?

Who is permitted to hold the consent discussion, who may perform the blood draw, and who may inject PRP or apply it to microneedled skin all depend on the state and on the license involved, and the answers are not the same everywhere. This guide does not state any state's rule. For the delegation framework that governs injectable procedures, start with our national guide to who can inject Botox in the United States, which explains how licensure, supervision and delegation interact, and then check your own state in our med spa regulations by state hub. Whatever your state allows, the consent form should identify each person by name and credential, so that the chart shows who did what.

The Annotated PRP Consent Template, Section by Section

Each section below says what to include and why. Write the final text in your own plain language; the headings are a structure for your medical director to approve, not copy to paste.

Section 1: Patient and visit details

What to include: the patient's name and date of birth, the visit date, and a chart or appointment reference that links this form to one specific treatment record.

Why it matters: PRP is often sold in packages, and identical undated forms cannot be tied to any session. The visit reference lets a reviewer match the form, the draw record and the treatment note.

Section 2: Procedure description, including the blood draw and centrifugation

What to include: a short, step-by-step description in everyday words. First, a clinician will draw a sample of blood from a vein, usually in the arm. Second, the sample is placed in a sealed tube and spun in a centrifuge, a machine that separates the blood into layers so the platelet-rich portion can be collected. Third, that concentrate is returned to the patient in the way the treatment plan describes: injected into the treatment area, applied to skin that has just been microneedled, or both. Name the treatment areas individually, such as face, under-eye area or scalp, and say whether the practice is preparing PRP or PRF.

Why it matters: patients book PRP from a social media clip that shows the final application and none of the steps before it. A form that only says "PRP facial" does not show the patient knew a venipuncture was involved, and it is the draw that makes some patients faint.

What to leave out: spin speeds, spin times, blood volumes and platelet concentrations. Those numbers change with the kit and the protocol, and once printed on a consent form they become something a patient can argue was not followed. Record the kit and preparation method in the treatment note, where your SOP says they belong. Our compliance guide explains why the difference between PRP and PRF lies in how the sample is prepared, which is why the form should name the one you make.

Section 3: The autologous nature of the product

What to include: a plain statement that the concentrate is prepared from the patient's own blood, collected at this visit, kept identified as theirs throughout processing, and returned only to them. Add a sentence that no donor blood, donor cells or manufactured biologic is added, unless your protocol does add something, in which case that product must be named and disclosed separately.

Why it matters: the autologous point is why PRP sits in a lower-risk regulatory position than products such as exosomes, and patients find it reassuring. State it accurately without turning it into a safety promise: "your own blood" does not mean "no risk." Products marketed as exosomes raise separate questions covered in our guide on whether med spas can offer exosomes.

Section 4: Regulatory status of the treatment

What to include: that the centrifuge, tubes and kit used to prepare the concentrate are medical devices cleared by the FDA; that the FDA has not approved PRP itself as a treatment; and that using the concentrate for skin rejuvenation, hair restoration or alongside microneedling is an off-label use, meaning a use outside the specific indication the device was cleared for, decided on by a licensed clinician.

Why it matters: off-label use is a lawful part of medical practice, but the patient should hear it from you rather than discover it later. Our PRP compliance guide explains what the FDA clears and why off-label is not illegal. Do not go beyond that on the form, and avoid phrases such as "FDA approved" or "clinically proven," which overstate the position.

Section 5: Expected results and variability

What to include: that improvement, where it occurs, is usually gradual rather than immediate; that results vary from one patient to the next and may be modest; that more than one session may be recommended and maintenance sessions may be suggested; that some patients see little or no visible change; and that the practice cannot guarantee any particular outcome.

Why it matters: this is the section most PRP disputes are actually about. The treatment usually went as planned; the patient expected more. Write expectations conservatively and without numbers; a stated duration or percentage hands the patient a benchmark to measure you against. For scalp treatment, our compliance guide notes that the hair-restoration evidence is stronger than for most facial uses but that results vary and maintenance is typically needed. Match that tone: supported, not promised.

Section 6: Common effects the patient should expect

What to include: at the draw site, mild discomfort and bruising. At the treatment site, redness, swelling, tenderness, bruising at injection points, and a temporary uneven or lumpy feel. Where PRP is applied to microneedled skin, the redness and pinpoint bleeding of microneedling itself. Say that these normally settle as the skin recovers, without putting a day count on it.

Why it matters: a patient never told to expect a bruised arm may decide the draw was botched. Keeping common effects apart also stops the risk list reading like trivia.

Section 7: Risks and side effects

What to include: each risk on its own line, described in a sentence a patient can follow, with a space for the patient's initials. A typical PRP list includes:

• Blood draw reactions. Bruising, soreness or a small collection of blood under the skin at the draw site; lightheadedness or fainting during or after the draw; and, uncommonly, irritation of the vein or nearby nerve.
• Infection. Any needle, whether at the draw site or the treatment site, can introduce infection. Infection may need treatment and can affect the result.
• Bloodborne pathogen considerations. Because the procedure involves drawing, handling and returning blood, the practice follows strict single-use, labeling and infection-control procedures. Say that it does, briefly, because that is what the patient is relying on.
• Prolonged swelling, bruising or tenderness beyond what is normally expected.
• Lumps, irregularity or asymmetry in the treated area.
• Pigment change at injection or treated sites, particularly where PRP is combined with microneedling.
• Allergic or irritant reaction to numbing agents, skin preparation products or anything else applied during treatment.
• Unsatisfactory or limited result, including no visible improvement.

Your medical director may add risks specific to the treatment sites, delivery technique and products the practice uses, starting from the processing kit's labeling and your clinical protocol. When PRP is applied to microneedled skin, the microneedling risks also apply and must appear, as covered in the combined-consent note below.

What to leave out: complication rates and comfort words. "Extremely rare," "virtually risk-free" and "completely natural" all soften a disclosure you have no reliable figure to support. Say plainly that each risk can occur even when the procedure is performed correctly.

Section 8: Contraindication screening

What to include: questions the patient answers in writing before the draw, with a line for the practitioner to initial that the answers were reviewed. Typical questions are:

• Have you been told you have a blood disorder, a low platelet count or a problem with blood clotting?
• Do you take blood thinners, anti-inflammatory medicines, or supplements that affect bleeding?
• Do you currently have an infection, a fever, or an active skin infection, rash or open sore in the area to be treated?
• Have you ever fainted or felt faint during a blood draw or injection?
• Do you have a condition, or take a medication, that affects your immune system or how you heal?
• Are you pregnant, trying to become pregnant, or breastfeeding?
• Have you had cancer, or are you being treated for any serious illness?
• Do you have allergies, including to numbing creams, skin cleansers, latex or adhesive dressings?
• For facial treatment: have you had cold sores, and have you had filler, toxin or another procedure in the area recently?

Why it matters: the screening questions are prompts for clinical judgment, not automatic rules, and the form should say so. What any answer means for the treatment is for the practitioner to decide, applying the protocol your medical director has approved. Keep questions on the form and decision rules in the protocol. The screening feeds into the good-faith exam that should precede the first treatment; our good-faith exam guide explains how that exam fits the sequence, and our intake form template guide covers the health history behind it.

Section 9: Alternatives

What to include: that other options exist and were discussed. For facial rejuvenation those might be microneedling without PRP, chemical peels, laser or other energy-based treatments, topical skincare, or injectable treatments. For hair loss, they might be topical or oral medications prescribed by a clinician, other procedures, or referral to a specialist. In every case, include the option of not treating.

Why it matters: the form need not rank the alternatives; it must show the patient chose PRP knowing others existed, a basic element generic forms often skip.

Section 10: Photography consent

What to include: consent to standardized clinical photographs before and after treatment, stored in the medical record. A separate line, or better a separate document, for any use of those images in marketing, social media or training.

Why it matters: with a treatment whose results are gradual and variable, baseline photographs are often the only objective evidence of change. They protect the practice in an expectation dispute. Marketing use is a different decision, with its own revocable authorization; our before-and-after photo rules guide covers what advertising use requires.

Section 11: Aftercare acknowledgment and warning signs

What to include: a statement that the patient received written aftercare instructions and went through them with the practitioner. The detailed instructions live on a separate handout that can be updated with the protocol; our aftercare instructions template guide covers what that handout should contain. Then, on the form itself, the warning signs: pain, swelling or redness that is getting worse rather than better; warmth, pus, spreading redness or fever, which may signal infection; a painful, hard or growing lump at the draw site; skin that changes color or blisters; and a rash or hives. Any difficulty breathing, or swelling of the face, lips or throat, should be treated as an emergency. Print a contact number that is answered outside office hours, or say exactly what the patient should do when the practice is closed.

Why it matters: warning signs are part of the risk disclosure, not just aftercare.

Section 12: Financial terms

What to include: the fee for the session or package, what a package covers, the cancellation and rescheduling terms, and the refund policy for unused sessions. State that the treatment is elective and the fee is the patient's responsibility, and that paying for a session or a package is not a guarantee of any result. If the practice has a policy on refunds when a patient is unhappy with the outcome, state it or refer to the written policy the patient has received.

Why it matters: PRP is frequently sold as a multi-session package, and package refunds are a common flashpoint once a patient decides the treatment "isn't working." Writing the terms into the consent, or attaching the signed financial policy, separates the money question from the clinical one.

Section 13: Signatures, witness and date

What to include: an attestation in the first person: I have read this form; I was given the chance to ask questions and they were answered; the health information I provided is complete and accurate; I understand the treatment is off-label and results are not guaranteed; I agree to the blood draw and the treatment described. Then the patient's signature and date, signed before the draw; the printed name, credential and signature of the practitioner who held the discussion; the name and credential of the person who performed the draw and of the person who performed the treatment, where they are different; a witness signature if your policy calls for one; and the form version number in the footer.

Why it matters: a PRP visit can involve two or three people touching the patient in sequence. If the form has one illegible signature line, the chart cannot show who drew the blood or who treated. Whether a witness is required is a question for counsel; where one is used, they must actually watch the patient sign.

Section 14: The consent-giver line

What to include: a short practitioner statement, separate from the patient attestation, confirming that the practitioner explained the procedure, the off-label status, the risks and the alternatives, invited questions, and believes the patient understood. Leave space for a free-text note of anything patient-specific that was discussed.

Why it matters: the consent discussion belongs to a clinician who can answer medical questions about the draw, the processing and the treatment, not to a coordinator selling a package. The practitioner's own statement makes that visible.

The PRP Consent Template at a Glance

The table condenses the sections above into reading order. It is a structure, not wording.

PRP With Microneedling: One Consent or Two?

Microneedling with topical PRP, often marketed as a "vampire facial," is two procedures delivered in one appointment. The patient is consenting to the microneedling, with its own risks of infection, scarring and pigment change in opened skin, and to the blood draw and the application of their concentrate to that skin. The consent has to cover both, and the practitioner has to discuss both.

There are two workable approaches. Some practices use their standard microneedling consent plus a separate PRP consent, each signed. Others use a single combined form with a clearly separate PRP section that carries its own initials or signature, so the patient's agreement to the draw is recorded explicitly. Either is defensible if the PRP disclosure is distinct and the forms signed match the treatment performed. What is not defensible is a microneedling form with "PRP optional" in a checkbox and no description of the draw, the processing or the off-label status.

Complete the screening for both procedures before the draw. Our microneedling consent form template guide sets out the microneedling side of the combined form, including the separate disclosures for RF microneedling, and our microneedling scope guide covers who may perform the needling itself.

Does Each PRP Treatment Area Need Its Own Form?

Not necessarily, but each area does need its own accurate description. Facial injection, under-eye treatment, scalp treatment for hair loss and topical application after microneedling differ in how the concentrate is delivered, what the patient should expect and which alternatives are relevant. A single PRP form can cover them if the treatment section names the area being treated at this visit and the expectations language fits it. Hair restoration is the clearest case for area-specific wording: the expectations section should address variable response and ongoing maintenance in terms that fit hair rather than skin.

What PRP Consent Mistakes Show Up in Complaints?

When a PRP file is pulled for a board inquiry or a claim, the weaknesses are usually a mismatch between the form and the visit.

The blood draw is not mentioned

A form that describes the facial or the injection but never says a venipuncture comes first leaves the most physical part of the visit undocumented. If the patient faints or develops a painful bruise on their arm, the practice will struggle to show it was disclosed.

"Natural" is used as a risk disclosure

"Since PRP uses your own blood, there are no allergic reactions or rejection risks" is the sort of sentence that appears on downloaded forms and marketing pages. It treats autologous as risk-free and ignores infection, draw-site complications and reactions to anything else used.

No off-label statement

A patient who discovers that aesthetic PRP is off-label use of a device, having never been told, has an easy argument that consent was incomplete.

Results described as a promise

"Visible results after three sessions," a stated duration, or a before-and-after photo stapled to the form all set a benchmark. When the patient misses it, the form becomes evidence for them, not you. Keep expectations general, variable and unguaranteed.

The form is a hair clinic's or a different kit's

Copied forms often name a kit you do not use, describe a preparation method you do not follow, or assume a delivery route you do not offer. A reviewer comparing the form with the treatment note will spot the mismatch immediately.

One signature line for three roles

The clinician who held the conversation, the person who drew the blood and the person who treated may be different people. A form that cannot show which of them did what makes it harder to establish that every step was performed by someone permitted to perform it.

Screening done after the draw

If the screening section is dated or initialed after the treatment time, or not initialed at all, the form cannot show that bleeding risk, infection or fainting history was considered before the needle went in.

Is There a Free PRP Consent Form PDF You Can Use?

Free PRP consent PDFs are easy to find, but none is ready to use as downloaded. Treat one as raw material: adapt it to your kit, delivery routes and practitioner roles, rewrite it in your own words, and have your medical director approve it and counsel review it before any patient signs.

Downloaded PRP forms tend to fail in the same ways. Many were written for hair restoration and ignore facial injection or microneedling. Many print preparation figures or timelines that may not match your protocol. Some call PRP risk-free or omit the off-label statement, and few separate the person who drew the blood from the person who treated.

Use the element list at the top of this page as your checklist. Delete what does not describe how you treat, add what your kit and routes need, and record the approval date and version. Do not reproduce a kit manufacturer's patient materials as your consent; use the device labeling as a source for what must be disclosed, then write the form yourself.

How Should You Document and Keep PRP Consent?

A PRP consent is only as strong as the chart around it.

Tying the consent to the draw and treatment records

For each visit, the chart should hold the signed consent or a reference to the current one, the screening answers with the practitioner's review, the good-faith exam or treatment order, a record of the draw and who performed it, the kit and preparation method, the delivery route and areas treated, any topicals or numbing agents used, pre-treatment photographs, confirmation that aftercare was given, and any adverse event with its follow-up. The product and areas on the form should match the note. Our compliance guide sets out what the PRP chart record should capture, and the blood-handling side is covered in our infection control protocol guide.

Record retention

A signed PRP consent is part of the patient's medical record and is kept for as long as that record must be kept. The retention period is set by state law and other obligations, not by the type of treatment, and records of minors are often handled differently. There is no PRP-specific rule to apply. Our medical records retention guide sets out how to determine the period that applies to you. Keep each retired version of the template alongside a log of when it took effect and who approved it, so you can show exactly what a patient signed years later.

Electronic consent

Tablet and portal signatures work well for PRP if the system records who signed, when, and exactly which version of the form they saw, and preserves that text after the template is edited. The risk and off-label sections should be on screen before the signature becomes available. Confirm with counsel that your platform meets the requirements that apply to you.

When to re-consent

Refresh consent whenever something material changes: a switch between PRP and PRF, a new treatment area or delivery route, adding microneedling or another add-on, a change in the patient's health or medications revealed by updated screening, a complication at an earlier session, a new form version, or a change in who performs the draw or the treatment where that matters to the patient's agreement. Whether you take a full consent every session or a series consent with visit-level confirmation, write the policy down and apply it consistently.

Key Takeaways

• Describe every step: the blood draw, the centrifuge processing and the delivery route, and name PRP or PRF.
• State that the product is autologous, without implying that "your own blood" means "no risk."
• Say that the processing device is FDA-cleared, that PRP itself is not an approved treatment, and that aesthetic use is off-label.
• Keep expectations gradual, variable and unguaranteed, and keep numbers off the form.
• Name draw-site and treatment-site risks individually, and screen before the draw.
• For PRP with microneedling, cover both procedures with a distinct PRP disclosure.
• Identify the consent-giver, the person who drew the blood and the treating practitioner by name and credential.
• Who may do each step varies by state; your medical director approves the form and counsel reviews it.

This guide is general information about how platelet-rich plasma consent forms are structured and maintained. It is neither legal nor medical advice; it creates no clinical standard and describes no state's law. Your practice's medical director must approve every consent form, and a healthcare attorney licensed in your state should review it before use. Check the risk disclosures against the current labeling of the processing kit you use.